Characteristics and Outcomes of Intensive Care Unit Patients Admitted With Novel H1N1 Influenza or Seasonal Influenza
NCT01011582 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4
Last updated 2013-01-08
Summary
The purpose of this research study is to collect information on problems that patients with the novel H1N1 influenza and/or the seasonal influenza experience. Novel H1N1 flu is also called the swine flu. Seasonal influenza is also called the regular flu. The purpose of this study is to collect information from patients who are infected with either the novel H1N1 or the seasonal flu and to determine what makes patients critically ill with these infections. The goal is to develop a registry that will aid investigators in determining specific markers that lead to development of severe illness in these infections.
Conditions
- H1N1 Influenza
- Seasonal Influenza
Sponsors & Collaborators
-
Virginia Commonwealth University
lead OTHER
Principal Investigators
-
Marjolein de Wit, M.D., M.S. · Virginia Commonwealth University
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-11-30
- Primary Completion
- 2010-06-30
- Completion
- 2010-06-30
Countries
- United States
Study Locations
More Related Trials
-
High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients
NCT04613206 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Optimizing the Influenza Clinical Decision Support Tool
NCT03415425 ·Status: COMPLETED ·Phase: NA
-
Influenza Virus - A Multicenter Registry
NCT01256255 ·Status: COMPLETED
-
Influenza Vaccine Responses as a Means of Assessing Immune Competence in Chimeric Kidney/Stem Cell Transplant Recipients
NCT02623075 ·Status: COMPLETED
-
Prospective Study of AI H5N1 in China
NCT00428493 ·Status: COMPLETED
-
Immune Response to High-Dose vs. Standard Dose Influenza Vaccine
NCT02297542 ·Status: UNKNOWN ·Phase: PHASE4
-
Influenza Vaccine Safety and Effectiveness in Healthcare Providers
NCT01282177 ·Status: COMPLETED
-
Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49 Years
NCT01560793 ·Status: COMPLETED ·Phase: PHASE1
-
Inpatient Influenza Surveillance
NCT00419861 ·Status: COMPLETED
-
High Dose Influenza Vaccine in Nursing Home - Pilot Study
NCT01720277 ·Status: COMPLETED ·Phase: PHASE4
-
Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk Patients
NCT01022905 ·Status: COMPLETED ·Phase: PHASE4
-
Influenza HA Ferritin Vaccine, Alone or in Prime-Boost Regimens With an Influenza DNA Vaccine in Healthy Adults
NCT03186781 ·Status: COMPLETED ·Phase: PHASE1
-
Brief Influenza Vaccine Education to Pregnant Women
NCT01772901 ·Status: COMPLETED ·Phase: NA
-
Immune Response to Influenza Vaccine in Islet Cell Transplant Recipients
NCT01149382 ·Status: COMPLETED
-
China Case Control Avian Influenza
NCT00428753 ·Status: COMPLETED
-
Cellular and Molecular Characterization of the Immune Response in Healthy NIH Employees atBaseline, and After Immunization With the H1N1 or Seasonal Influenza Vaccines
NCT01191853 ·Status: COMPLETED
-
Acute Respiratory Infection Consortium
NCT01021098 ·Status: ACTIVE_NOT_RECRUITING
-
Safety and Immunogenicity Study of a H5N1 Influenza Vaccine (Vero Cell-Derived, Whole Virus) in Healthy Infants, Children and Adolescents
NCT01052402 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Standard-dose Versus High-dose Flu Vaccine in Solid Organ Transplant.
NCT01808456 ·Status: COMPLETED ·Phase: PHASE4
-
Respiratory Virus Outpatient Study (FLU 002 Plus)
NCT01056354 ·Status: COMPLETED
-
Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49
NCT01658800 ·Status: COMPLETED ·Phase: PHASE1
-
High-Dose Influenza Vaccine in Nursing Homes
NCT01815268 ·Status: UNKNOWN ·Phase: PHASE4
-
Influenza Vaccine in Lung Transplant Patients
NCT00205270 ·Status: COMPLETED
-
H1N1v Vaccination of Pregnant Women: A Longitudinal Cohort Study Characterizing Influenza A H1N1v Vaccination in Pregnant Women
NCT01012557 ·Status: COMPLETED ·Phase: NA
-
Long-term Observation of Hemagglutinin and Neuraminidase Inhibition Antibody Titers After Influenza Challenge
NCT02511002 ·Status: ENROLLING_BY_INVITATION